The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.15 (0.10%)
Spread: 4.50 (3.093%)
Open: 147.60
High: 147.75
Low: 147.60
Prev. Close: 147.60
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Shire plc

26 Sep 2018 15:39

RNS Number : 0515C
Santander UK Plc
26 September 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Santander UK Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

25/09/2018

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

7,643,287

0.8753

(2) Cash-settled derivatives:

 

7,643,287

0.8753

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

7,643,287

0.8753

7,643,287

0.8753

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

5p Ordinary

Sale

8,000,000

45.05 GBP

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

5p Ordinary

Total return swap

Decreasing short position

8,000,000

45.05 GBP

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

26 September 2018

Contact name:

Laura Sweeney

Telephone number:

020 7756 3767

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETBSGDCRBDBGIL
Date   Source Headline
23rd Feb 20175:39 pmRNSPublication of Suppl.Prospcts
23rd Feb 20177:15 amRNSNotice of AGM
23rd Feb 20177:15 amRNSNotice of AGM
23rd Feb 20177:15 amRNSAnnual Financial Report
23rd Feb 20177:15 amRNSAnnual Financial Report
22nd Feb 20173:18 pmRNSPublication of Final Terms
2nd Feb 20174:58 pmRNSDirectorate Change
31st Jan 20173:12 pmRNSPublication of Suppl.Prospcts
26th Jan 20176:01 pmRNSPublication of Supplementary Prospectus
25th Jan 20177:15 amRNSQuarterly Management Statement - 31 December 2016
30th Nov 20167:22 amRNSOutcome of the 2016 Bank of England Stress Tests
10th Nov 201611:32 amRNSNotice of Early Redemption
26th Oct 20164:04 pmRNSPublication of Suppl.Prospcts
26th Oct 20163:44 pmRNSPublication of Suppl.Prospcts
26th Oct 20167:45 amRNS3rd Quarter Results
8th Sep 20166:18 pmRNSPublication of Final Terms
8th Sep 20162:38 pmRNSPublication of Final Terms
31st Aug 20163:59 pmRNSPublication of a Prospectus
16th Aug 20163:38 pmRNSPublication of Supplementary Prospectus
16th Aug 20163:12 pmRNSPublication of Supplementary Prospectus
16th Aug 201612:33 pmRNSHalf-year Report
16th Aug 20167:45 amRNSHalf-year Report
27th Jul 20164:55 pmRNSPublication of Suppl.Prospcts
27th Jul 20164:54 pmRNSPublication of Suppl.Prospcts
27th Jul 20167:45 amRNSQMS for 6 Months Ended 30 June 2016
11th Jul 201612:34 pmRNSPublication of Final Terms
6th Jul 201612:17 pmRNSPublication of Final Terms
30th Jun 20165:43 pmRNSPublication of Suppl.Prospcts
1st Jun 201612:57 pmRNSPublication of Prospectus
27th Apr 20161:45 pmRNSPublication of Suppl.Prospcts
27th Apr 20168:17 amRNSNotice of Substitution
27th Apr 20168:15 amRNSNotice of Substitution
27th Apr 20167:45 amRNS1st Quarter Results
1st Apr 20167:30 amRNSResult of AGM
1st Apr 20167:30 amRNSResult of AGM
2nd Mar 20165:41 pmRNSPublication of Supplementary Prospectus - Replace.
2nd Mar 20165:15 pmRNSPublication of Supplementary Prospectus
2nd Mar 20164:54 pmRNSPublication of Supplementary Prospectus
25th Feb 20167:30 amRNSNotice of AGM
25th Feb 20167:30 amRNSAnnual Financial Report
25th Feb 20167:30 amRNSDirectorate Change
12th Feb 20165:01 pmRNSNotice to Holders of Early Redemption
27th Jan 20167:44 amRNSQuarterly Management Statement - 31 December 2015
13th Jan 20167:30 amRNSDirectorate Change
22nd Dec 20152:30 pmRNSDirectorate Change
1st Dec 20157:45 amRNSStress Test Results
29th Oct 20157:30 amRNS3rd Quarter Results
2nd Oct 20159:00 amRNSDirectorate Change
7th Sep 20154:29 pmRNSEarly Redemption
7th Sep 20154:29 pmRNSEarly Redemption

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.